Literature DB >> 21537671

Detection of rifampin-resistant genotypes in Mycobacterium tuberculosis by reverse hybridization assay.

Raquel de A Maschmann1, Mirela Verza, Marcia Sn Silva, Rosa Dea Sperhacke, Marta O Ribeiro, Philip Noel Suffys, Harrison Magdinier Gomes, Enrico Tortoli, Fiorella Marcelli, Arnaldo Zaha, Maria Lucia R Rossetti.   

Abstract

We used a colorimetric reverse dot blot hybridization (CRDH) assay to detect the presence of mutations in a specific region of the rpoB gene, associated with rifampin (RIF) resistance, in a panel of 156 DNAs extracted from 103 RIF-sensitive and 53 RIF-resistant cultures of Mycobacterium tuberculosis. When compared with the antimicrobial susceptibility test (AST), the sensitivity and specificity of the CRDH were 92.3% and 98.1%, respectively. When compared with sequencing, the sensitivity and specificity of the CRDH were 90.6% and 100%, respectively. To evaluate the performance of the assay directly in clinical specimens, 30 samples from tuberculosis patients were used. For these samples, the results of the CRDH were 100% consistent with the results of the AST and sequencing. These results indicate that the rate of concordance of the CRDH is high when compared to conventional methods and sequencing data. The CRDH can be successfully applied when a rapid test is required for the identification of RIF resistance in M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537671     DOI: 10.1590/s0074-02762011000200004

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  6 in total

1.  De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.

Authors:  Jees Sebastian; Sharmada Swaminath; Rashmi Ravindran Nair; Kishor Jakkala; Atul Pradhan; Parthasarathi Ajitkumar
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

2.  Rolling circle amplification for direct detection of rpoB gene mutations in Mycobacterium tuberculosis isolates from clinical specimens.

Authors:  Xiaoyou Chen; Bin Wang; Wen Yang; Fanrong Kong; Chuanyou Li; Zhaogang Sun; Peter Jelfs; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

3.  Performance of the GenoType MTBDRplus assay directly on sputum specimens from Brazilian patients with tuberculosis treatment failure or relapse.

Authors:  Raquel de Abreu Maschmann; Fernanda Sá Spies; Luciana de Souza Nunes; Andrezza Wolowski Ribeiro; Taís Raquel Marcon Machado; Arnaldo Zaha; Maria Lucia Rosa Rossetti
Journal:  J Clin Microbiol       Date:  2013-03-06       Impact factor: 5.948

4.  Performance of a molecular assay to detect Mycobacterium tuberculosis complex DNA in clinical specimens: multicenter study in Brazil.

Authors:  Mirela Verza; Karen Barros Schmid; Regina Bones Barcellos; Natali Linck; Graziele Lima Bello; Daniel Scapin; Rosa Dea Sperhacke; Márcia Susana Nunes Silva; Claudia Wollheim; Martha Gabriela Celle Rivero; Afrânio Lineu Kritski; Leonides Rezende; Martha Maria Oliveira; Elis Regina Dalla Costa; Maria Lucia Rosa Rossetti
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-02       Impact factor: 2.743

5.  Evaluation of biochip system in determining isoniazid and rifampicin resistances of mycobacterium tuberculosis in sputum samples.

Authors:  Wei Lu; Cheng Chen; Yan Shao; Jinyan Shi; Chongqiao Zhong; Dandan Yang; Honghuan Song; Guoli Li; Xiaoyan Ding; Hong Peng; Linyang Zhu; Yang Zhou; Limei Zhu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

6.  In house reverse membrane hybridisation assay versus GenoType MTBDRplus and their performance to detect mutations in the genes rpoB, katG and inhA.

Authors:  Sergio Luiz Montego Ferreira Junior; Elis Regina Dalla Costa; Paula Gonçalves dos Santos; Harrison Magdinier Gomes; Marcia Susana Nunes Silva; Leonardo Souza Esteves; Martha Maria Oliveira; Raquel de Abreu Maschmann; Afrânio Lineu Kritski; Philip Noel Suffys; Maria Lucia Rosa Rossetti
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-05-07       Impact factor: 2.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.